Date Posted: 2010-02-15 11:30 New Issue: Oxford Nutrascience Group Plc ( ONG is incorporated in England and Wales and is the holding company of Oxford Nutrascience Limited ('ONL'), a consumer healthcare company developing and commercialising advanced delivery systems for medicines and supplements leveraging prebiotic soluble fibre technology. Oxford Nutrascience's proprietary delivery systems include advanced chewable tablets, chewy confectionery and liquid suspensions that make self medication easier and also have functional benefits. ONL was founded in February 2008 by two entrepreneurs with corporate experience in consumer healthcare. Nigel Theobald, Chief Executive Officer, previously worked for Boots (now Alliance Boots) where he held senior commercial roles in Over-the-Counter ('OTC') medicines and healthcare product development. Marcelo Bravo, Non Executive Chairman, has a background in chemistry and chemical engineering and previously worked in research and development with Procter & Gamble, and new business development with Boots.
Revenues, to date, are derived from the trade of Ellactiva®, a calcium chewy supplement which is sold in the UK, via Boots, and in the Middle East, via Hauora Products Limited. ONG is seeking to license the IP rights to the Technology to major brand owners in the OTC and prescription pharmaceutical sectors.
Listing exchange: AIM
Expected first day of trading: 2010-02-12
Expected money raised: £1.1m Any information, prospectus or other document, or any hypertext link to any of the aforesaid should not be construed as advice on investments or a personal recommendation by ALL IPO plc and is being offered on an execution-only basis. Any decision to invest should be made only after careful consideration of the relevant documentation and particularly after acceptance of the full terms and conditions relating to the specific investment opportunity. Share prices, values and income can go down as well as up and you may get back less than the amount you invested. If in doubt about the suitability of investments referred to in this communication and on our website, you should consult an investment adviser authorised under the Financial Services and Markets Act 2000. |